Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Current Assets (2016 - 2025)

Conmed's Current Assets history spans 16 years, with the latest figure at $672.9 million for Q4 2025.

  • For Q4 2025, Current Assets rose 5.13% year-over-year to $672.9 million; the TTM value through Dec 2025 reached $672.9 million, up 5.13%, while the annual FY2025 figure was $672.9 million, 5.13% up from the prior year.
  • Current Assets reached $672.9 million in Q4 2025 per CNMD's latest filing, up from $662.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $672.9 million in Q4 2025 to a low of $424.4 million in Q1 2021.
  • Average Current Assets over 5 years is $581.6 million, with a median of $615.6 million recorded in 2023.
  • Peak YoY movement for Current Assets: skyrocketed 30.24% in 2022, then grew 0.52% in 2025.
  • A 5-year view of Current Assets shows it stood at $460.1 million in 2021, then grew by 26.32% to $581.2 million in 2022, then increased by 5.92% to $615.6 million in 2023, then increased by 3.96% to $640.0 million in 2024, then increased by 5.13% to $672.9 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Current Assets are $672.9 million (Q4 2025), $662.2 million (Q3 2025), and $657.8 million (Q2 2025).